Welcome to LookChem.com Sign In|Join Free

CAS

  • or
Oxazole, 4-(4-fluorophenyl)(9CI) is a heterocyclic chemical compound with the molecular formula C9H6FNO. It is an oxazole derivative featuring a four-fluorophenyl substituent, which is known for its wide range of biological activities. Oxazole, 4-(4-fluorophenyl)(9CI) is commonly utilized in the pharmaceutical and chemical industries due to its potential applications in medicinal chemistry research and drug development. The unique structure of the oxazole ring, combined with the 4-(4-fluorophenyl) substitution, may confer specific properties or activities, making it a valuable compound for various chemical synthesis processes and material science applications.

620633-04-7 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 620633-04-7 Structure
  • Basic information

    1. Product Name: Oxazole, 4-(4-fluorophenyl)- (9CI)
    2. Synonyms: Oxazole, 4-(4-fluorophenyl)- (9CI);4-(4-fluorophenyl)oxazole
    3. CAS NO:620633-04-7
    4. Molecular Formula: C9H6FNO
    5. Molecular Weight: 163.1484432
    6. EINECS: N/A
    7. Product Categories: HALIDE
    8. Mol File: 620633-04-7.mol
  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: N/A
    3. Flash Point: N/A
    4. Appearance: /
    5. Density: N/A
    6. Refractive Index: N/A
    7. Storage Temp.: 2-8°C
    8. Solubility: N/A
    9. CAS DataBase Reference: Oxazole, 4-(4-fluorophenyl)- (9CI)(CAS DataBase Reference)
    10. NIST Chemistry Reference: Oxazole, 4-(4-fluorophenyl)- (9CI)(620633-04-7)
    11. EPA Substance Registry System: Oxazole, 4-(4-fluorophenyl)- (9CI)(620633-04-7)
  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 620633-04-7(Hazardous Substances Data)

620633-04-7 Usage

Uses

Used in Pharmaceutical Industry:
Oxazole, 4-(4-fluorophenyl)(9CI) is used as a key intermediate in the synthesis of various pharmaceutical compounds for its potential biological activities. The 4-(4-fluorophenyl) substitution on the oxazole ring may enhance the compound's pharmacological properties, such as improving binding affinity to target proteins or modulating specific biological pathways.
Used in Medicinal Chemistry Research:
In the field of medicinal chemistry, Oxazole, 4-(4-fluorophenyl)(9CI) serves as a valuable research tool for the development of novel therapeutic agents. Its unique structure allows for the exploration of new chemical space and the design of innovative drug candidates with improved potency, selectivity, and pharmacokinetic properties.
Used in Chemical Synthesis Processes:
Oxazole, 4-(4-fluorophenyl)(9CI) is employed as a versatile building block in various chemical synthesis processes. Its reactivity and functional group compatibility make it suitable for the preparation of a wide range of organic compounds, including agrochemicals, dyes, and other specialty chemicals.
Used in Materials Science:
Oxazole, 4-(4-fluorophenyl)(9CI) may also find applications in materials science, where its unique structural features and potential interactions with other molecules could be harnessed to develop new materials with specific properties, such as improved stability, conductivity, or responsiveness to external stimuli.

Check Digit Verification of cas no

The CAS Registry Mumber 620633-04-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 6,2,0,6,3 and 3 respectively; the second part has 2 digits, 0 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 620633-04:
(8*6)+(7*2)+(6*0)+(5*6)+(4*3)+(3*3)+(2*0)+(1*4)=117
117 % 10 = 7
So 620633-04-7 is a valid CAS Registry Number.

620633-04-7SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 16, 2017

Revision Date: Aug 16, 2017

1.Identification

1.1 GHS Product identifier

Product name 4-(4-Fluorophenyl)-1,3-oxazole

1.2 Other means of identification

Product number -
Other names Oxazole,4-(4-fluorophenyl)

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:620633-04-7 SDS

620633-04-7Relevant articles and documents

SUBSTITUENT-INCLUDING UREA COMPOUND

-

Paragraph 0620-0623, (2021/12/03)

An object of the present invention is to provide a compound that has a specific chemical structure having an activation effect on SIRT6 and is useful as an active component for preventing and treating inflammatory diseases. The present invention relates to a compound represented by Formula (1) or a pharmaceutically acceptable salt thereof. (Each symbol in Formula (1) has the same definition as that described in the specification.)

Discovering novel chemical inhibitors of human cyclophilin A: Virtual screening, synthesis, and bioassay

Li, Jian,Chen, Jing,Gui, Chunshan,Zhang, Li,Qin, Yu,Xu, Qiang,Zhang, Jian,Liu, Hong,Shen, Xu,Jiang, Hualiang

, p. 2209 - 2224 (2007/10/03)

Cyclophilin A (CypA) is a member of cyclophilins, a family of the highly homologous peptidyl prolyl cis-trans isomerases (PPIases), which can bind to cyclosporin A (CsA). CypA plays critical roles in various biological processes, including protein folding, assembly, transportation, regulation of neuron growth, and HIV replication. The discovery of CypA inhibitor is now of a great special interest in the treatment of immunological disorders. In this study, a series of novel small molecular CypA inhibitors have been discovered by using structure-based virtual screening in conjunction with chemical synthesis and bioassay. The SPECS_1 database containing 85,000 small molecular compounds was searched by virtual screening against the crystal structure of human CypA. After SPR-based binding affinity assay, 15 compounds were found to show binding affinities to CypA at submicro-molar or micro-molar level (compounds 1-15). Seven compounds were selected as the starting point for the further structure modification in considering binding activity, synthesis difficulty, and structure similarity. We thus synthesized 40 new small molecular compounds (1-6, 15, 16a-q, 17a-d, and 18a-l), and four of which (compounds 16b, 16h, 16k, and 18g) showed high CypA PPIase inhibition activities with IC50s of 2.5-6.2 μM. Pharmacological assay indicated that these four compounds demonstrated somewhat inhibition activities against the proliferation of spleen cells.

Triaryl-oxy-aryl-spiro-pyrimidine-2,4,6-trione metalloproteinase inhibitors

-

Page 42, (2010/02/05)

The present invention relates to triaryl-oxy-aryl-spiro-pyrimidine-2,4,6-trione metalloproteinase inhibitors of the formula 1wherein said ring X is a 5-7 membered heterocyclic ring, and wherein A, Y, B, G, and W are as defined in the specification; and t

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 620633-04-7